Health News (Reuters)

Exelixis drug improves overall survival in liver cancer patients

(Reuters) - Exelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert group to recommend no further trial, sending the company's shares soaring 31 percent.

Novo Nordisk diabetes drug works; no heart risk-FDA review

(Reuters) - Novo Nordisk A/S's closely watched diabetes drug semaglutide is effective, caused no heart risk, and carried only limited risk of sight problems, a preliminary review by the U.S. Food and Drug Administration concluded on Monday, sending the company's shares up 4 percent.

Pharma and medtech industries prepare for hard Brexit

LONDON (Reuters) - Drugmakers and medical devices companies are drawing up plans to protect supply chains in case Britain crashes out of the European Union without a trade deal, and some small service businesses are already relocating to stay inside the bloc.

Israel targets fashion industry over underweight models

TEL AVIV (Reuters) - Israeli lawmakers want to tighten a ban on the employment of underweight models and on the undeclared digital slimming-down of fashion images, amid concern that the measures are being routinely flouted even as they are adopted abroad.

Uruguay to produce medical marijuana for export

MONTEVIDEO (Reuters) - International Cannabis Corporation will produce Uruguay's first batch of medical cannabis oil for export in December, the company's chief executive said Sunday.

BrainStorm enrolls first patients in advanced ALS stem cell trial

TEL AVIV (Reuters) - BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS) at Massachusetts General Hospital and UC Irvine Medical Center in California.

Trump Obamacare move seen harming Americans, bipartisan prospects

WASHINGTON (Reuters) - U.S. President Donald Trump will hurt low-income Americans by doing away with Obamacare subsidies and make it harder for him to engage in bipartisan talks with Democrats as Congress edges toward a possible government shutdown, lawmakers said on Sunday.

U.S. states sue to block Trump Obamacare subsidies cut

WASHINGTON/SAN FRANCISCO (Reuters) - Eighteen U.S. states sued President Donald Trump's administration on Friday to stop him from scrapping a key component of Obamacare, subsidies to insurers that help millions of low-income people pay medical expenses, even as Trump invited Democratic leaders to negotiate a deal.

WHO says attack on Syria vaccine store leaves children at risk

LONDON (Reuters) - The World Health Organization said on Friday it had received reports of an attack on medical facilities in eastern Syria that had destroyed a store containing more than 130,000 vaccine doses against measles and polio.

After medical errors, patients want doctors to hear them out

(Reuters Health) - When medical errors lead to serious injuries, patients and families may feel better when doctors take the time to listen to their feelings about the mistake and explain what can be done to prevent it from happening again, a small study suggests.

J&J psoriasis drug gets expanded U.S. approval for teens

(Reuters) - Johnson & Johnson said on Friday it has received an expanded U.S. approval for its blockbuster psoriasis drug Stelara to treat adolescent patients aged 12 and over with moderate to severe cases of the unsightly skin condition.

U.S. states plan suit to block Trump Obamacare subsidies cut

WASHINGTON/SAN FRANCISCO (Reuters) - Eighteen U.S. states vowed to sue President Donald Trump's administration on Friday to stop him from scrapping a key component of Obamacare, subsidies to insurers that help millions of low-income people pay medical expenses, even as Trump invited Democratic leaders to negotiate a deal.

Little evidence new cancer drugs improve survival

(Reuters Health) - There’s not much evidence to show that most new cancer drugs approved in Europe in recent years can help patients live longer or improve their quality of life, a recent study suggests.

U.S. drops lawsuit against UnitedHealth after losing court ruling

(Reuters) - The U.S. government dropped a lawsuit accusing UnitedHealth Group Inc of submitting false claims to get inflated Medicare payouts, a court filing on Thursday showed, a week after a judge dismissed the complaint but said it could be amended.

U.S. FDA panel backs Aerie's glaucoma drug Rhopressa

(Reuters) - Aerie Pharmaceuticals Inc's experimental glaucoma treatment should be approved, an advisory committee to the U.S. Food and Drug Administration said on Friday, after it found the benefits outweigh the risks.

Pages